Eva Johansson

Title: Eva Johansson: Innovator in Antisecretory Factor Peptides

Introduction

Eva Johansson is a notable inventor based in Mölndal, Sweden. She has made significant contributions to the field of biomedical research, particularly in the development of innovative therapeutic proteins. Her work focuses on addressing pathological conditions related to fluid transport and inflammation.

Latest Patents

Eva Johansson holds a patent for "Antisecretory factor peptides regulating pathological permeability changes." This patent describes a new recombinant protein called Antisecretory Factor (rAF) and its homologues and peptide fragments. The rAF protein is useful for normalizing pathological fluid transport and inflammatory reactions in both animals and humans. The patent also covers antibodies against AF or its homologues and fragments, as well as nucleic acids coding for the protein. These innovations have potential applications in immunodetection, as feed additives for growing animals, and as antidiarrheal drugs for diseases involving edema, dehydration, and inflammation.

Career Highlights

Eva Johansson is associated with Rural Patent Svenska AB, where she continues to advance her research and development efforts. Her work has garnered attention for its potential impact on veterinary and human medicine.

Collaborations

Eva has collaborated with notable colleagues, including Ivar Lönnroth and Stefan Lange, to further her research initiatives. Their combined expertise enhances the development of innovative solutions in the field.

Conclusion

Eva Johansson's contributions to the field of biomedical research through her patented innovations demonstrate her commitment to improving health outcomes. Her work on Antisecretory Factor peptides is paving the way for new therapeutic approaches.